imipenem, anhydrous has been researched along with Pneumonia, Aspiration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, K; Haruna, A; Ichiyama, S; Ito, I; Kadowaki, S; Kase, M; Matsumoto, H; Mishima, M; Nakai, A; Niimi, A; Tanabe, N; Tsukino, M; Yasutomo, Y | 1 |
| Ye, XL; Yin, HY; Zhang, R; Zhu, YF | 1 |
| Kanno, H; Kikuchi, N; Kohno, N; Kubo, S; Kuriyama, T; Nagao, K; Okita, S; Onozaki, I; Tatsumi, K; Yamaguchi, T | 1 |
3 trial(s) available for imipenem, anhydrous and Pneumonia, Aspiration
| Article | Year |
|---|---|
Tazobactam/piperacillin for moderate-to-severe pneumonia in patients with risk for aspiration: comparison with imipenem/cilastatin.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cilastatin; Community-Acquired Infections; Drug Combinations; Female; Humans; Imipenem; Injections, Intravenous; Male; Nursing Homes; Penicillanic Acid; Piperacillin; Pneumonia, Aspiration; Prospective Studies; Protease Inhibitors; Tazobactam; Treatment Outcome | 2010 |
[Domestic imipenem cilastatin sodium for the treatment of severe aspiration pneumonia, a curative effect observation].
Topics: Aged; Aged, 80 and over; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Male; Pneumonia, Aspiration | 2012 |
[Clinical evaluation of therapy for aspiration pneumonia with imipenem/cilastatin sodium].
Topics: Aged; Aged, 80 and over; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Imipenem; Klebsiella pneumoniae; Male; Middle Aged; Multicenter Studies as Topic; Pneumonia, Aspiration; Pseudomonas aeruginosa; Staphylococcus aureus | 1990 |